Better survival among women after lung cancer surgery

There are known differences in the survival rates of women and men with lung cancer. Researchers at Karolinska Institutet set out to investigate potential reasons behind this disparity, such as the presence of other underlying diseases and smoking status. The study, which was published in Chest, shows that women have better survival rates after lung cancer surgery than men, independent […]

Continue reading »

Targeting calcium overload could improve stroke outcomes, research suggests

Excessive calcium contributes to harmful inflammation in ischemic stroke, and targeting it may provide doctors with a new way to improve patient outcomes, new research from the University of Virginia School of Medicine suggests. Petr Tvrdik, Ph.D., has found that immune cells called microglia are flooded with waves of calcium in the wake of ischemic strokes, which are strokes caused […]

Continue reading »

Study involving seven children’s hospitals shows COVID-19 typically mild in children

In the largest U.S. study of its kind to date, researchers at Children’s Hospital of Philadelphia (CHOP) and other PEDSnet sites report that of more than 135,000 pediatric patients tested for SARS-CoV-2 in pediatric health systems, 4% tested positive for the virus. However, the researchers also found patients from ethnic minorities, adolescents, patients with history of public insurance, and those […]

Continue reading »

Non-invasive electrolyte levels’ measuring method can prevent sudden cardiac death

Researchers from Kaunas University of Technology (KTU), Lithuania came up with the idea on how to measure fluctuating blood potassium levels non-invasively, through electrocardiogram. The researchers claim that their method may become a digital biomarker in the future for managing electrolyte levels. This would be a huge step towards preventing potentially life-threatening conditions among people who suffer from chronic kidney […]

Continue reading »

COVID-19 cases could nearly double before Biden takes office: study

President-elect Joe Biden has signaled that fighting the COVID-19 pandemic will be an immediate priority for his administration. He recently announced a coronavirus advisory board of infectious disease researchers and former public health advisers along with an updated strategy that will include increases in testing and contact tracing, as well as transparent communication. But Inauguration Day is still two months […]

Continue reading »

US approves Regeneron antibody treatment given to Trump

A COVID-19 antibody therapy used to treat President Donald Trump was approved by the US drug regulator on Saturday for people who aren’t yet hospitalized by the disease but are at high risk. The green light for drugmaker Regeneron came after REGEN-COV2, a combination of two lab-made antibodies, was shown to reduce COVID-19-related hospitalizations or emergency room visits in patients […]

Continue reading »

FDA Approves Zokinvy

FDA Approves Zokinvy (lonafarnib) for Hutchinson-Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies PALO ALTO, Calif., Nov. 20, 2020 /PRNewswire/ — Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved Zokinvy (lonafarnib) for the treatment of Hutchinson-Gilford Progeria Syndrome […]

Continue reading »
1 1,087 1,088 1,089 1,090 1,091 1,322